For the year ending 2025-12-31, PRVA had -$11,464K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 29,726 |
| Depreciation | 739 |
| Amortization of intangibles | 9,168 |
| Stock-based compensation | 71,068 |
| Deferred income taxes | 10,871 |
| Accounts receivable, net | 36,668 |
| Prepaid expenses and other current assets | 1,599 |
| Other non-current assets and right-of-use assets | 326 |
| Accounts payable and accrued expenses | 14,824 |
| Provider liability | 65,629 |
| Operating lease liabilities | -2,459 |
| Other long-term liabilities | 2,431 |
| Net cash provided by operating activities | 163,404 |
| Acquisitions, net of cash acquired | 180,370 |
| Other | 1,200 |
| Net cash used in investing activities | -181,570 |
| Repurchase of non-controlling interest | 0 |
| Proceeds from non-controlling interest | 0 |
| Distribution to non-controlling interest | 1,345 |
| Proceeds from exercised stock options | 8,047 |
| Net cash provided by financing activities | 6,702 |
| Net (decrease) increase in cash and cash equivalents | -11,464 |
| Cash and cash equivalents at beginning of period | 491,149 |
| Cash and cash equivalents at end of period | 479,685 |
Privia Health Group, Inc. (PRVA)
Privia Health Group, Inc. (PRVA)